Riskpilot← Back to searchSign inGet full accessIKAST FYSIOTERAPI II ApS
APSActiveCVR 36477288Ellehammervej 4Physiotherapy activities · NACE 8695Est. 2014— employees
Revenue 2024
—
EBITDA margin
—
-9% vs 2023
Equity ratio
76.8%
Financial strength
Net profit 2024
DKK 176K
-14% vs 2023
| Revenue | — | — |
| EBITDA | DKK 222K | -9% |
| Net profit | DKK 176K | -14% |
| Total assets | DKK 408K | -41% |
| Equity | DKK 313K | -51% |
| Employees | — | — |
Legal name
IKAST FYSIOTERAPI II ApS
CVR number
36477288
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
29. december 2014
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive fysioterapiklinik, herunder at deltage i interessentskaber der driver fysioterapiklinik samt dermed beslægtet virksomhed
Address
Ellehammervej 4
Phone
+4520973348
Email
jensoles@ikastfys.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 281 | 590 | 671 | 243 | 222 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 281 | 590 | 671 | 243 | 222 |
| Net financials | 293 | 607 | 688 | 276 | 240 |
| Profit before tax | 281 | 595 | 675 | 263 | 226 |
| Tax | 62 | 131 | 149 | 58 | 50 |
| Net profit | 219 | 464 | 527 | 205 | 176 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.290 | 1.315 | 1.101 | 697 | 408 |
| Equity | 1.191 | 1.155 | 932 | 637 | 313 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 77 | 149 | 169 | 21 | 63 |
| Total debt | 77 | 149 | 169 | 21 | 63 |
EBITDA margin
22160600.0%
This company
15.8%
Market median
+140256862% vs market
20202024
Equity ratio
76.8%
This company
38.2%
Market median
+101% vs market
20202024
Return on equity
56.3%
This company
18.4%
Market median
+206% vs market
20202024
Net profit margin
17626800.0%
This company
8.1%
Market median
+217614715% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Management | Management | 2025 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 90–99.99% | 90–99.99% | 2026 | |
| Individual | 100% | 100% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Jens Ole LS Holding ApS
IKAST FYSIOTERAPI II ApS Board members of IKAST FYSIOTERAPI II ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Ole Leth Staunstrup | Management | 0 companies |